Press Releases

RIDGEFIELD, Conn. and INDIANAPOLIS, Dec. 13, 2019 /PRNewswire/ -- Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) announced today results from the EMPERIAL-Reduced and EMPERIAL-Preserved trials related to functional endpoints with Jardiance® (empagliflozin) in adults with chronic heart failure with reduced and preserved ejection fraction,

DUBLIN, Calif., Dec. 13, 2019 /PRNewswire/ -- We learn early on that our skin is the largest organ on our body but there isn't much discussion on the best way to care for it. A quick search of skincare on the internet yields multiple results for how to care for your face and very few for what to do past that.

TEL AVIV, Israel, Dec. 13, 2019 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology, announced today updated data from the triple combination arm of the ongoing Phase 2a COMBAT/KEYNOTE-202 study. The data was delivered today in an oral presen

SAN DIEGO, Dec. 13, 2019 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq:AEMD) (the "Company"),  a medical device technology company focused on developing products to diagnose and treat life and organ threatening diseases, today announced the pricing of an underwritten public offering of 3,333,334 shares of common stock (which includes pre-funded warrants to purc

CAMP HILL, Pa., Dec. 13, 2019 /PRNewswire/ -- Consumers that enroll or renew their coverage in 2020 with Ambetter from PA Health & Wellness will have access to an en

INDIANAPOLIS, Dec. 13, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) issued a positive opinion recommending a new indication and associated label update for CYRAMZA® (ramucirumab). The Committee agreed that the label should include an i

SAN JOSE, Calif., Dec. 13, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, t

SHANGHAI, Dec. 13, 2019 /PRNewswire/ -- AT & IT China 2020, organized by Informa Markets and China Chamber of Commerce for Import & Export of Medicines & Health Products and co-organized by Shanghai Sinoexpo Informa Markets International Exhibition Co., Ltd., to take place at the Shanghai New Internation

LUND, Sweden, Dec. 13, 2019 /PRNewswire/ -- Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG-mediated diseases, today announced the outcome of a November 20th meeting with the U.S. Food and Drug Administration (FDA) to discuss a regulatory path forward for imlifidase in kidney transplantation of highly sensitize

MILFORD, Mass., Dec. 13, 2019 /PRNewswire/ -- Reprieve Cardiovascular®, a pioneering medical device company focused on improving outcomes for patients suffering from a